EpiPen maker Mylan, Pfizer's Upjohn off-patent drug business to merge | Gerald R. Ford School of Public Policy
 
International Policy Center Home Page
 
 
WHAT WE DO NEWS & EVENTS PEOPLE OPPORTUNITIES WEISER DIPLOMACY CENTER
 
In the Media

EpiPen maker Mylan, Pfizer's Upjohn off-patent drug business to merge

August 20, 2019 USA Today